Phentolamine Mesylate

Independent reference data for Phentolamine Mesylate (CAS 65-28-1), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Synonyms and trade names

Phentolamine mesylate; 65-28-1; phentolamine mesilate; Phentolamine methanesulfonate; OraVerse; Mesylate phentolamine; RYZUMVI; NV-101; Y7543E5K9T; DTXSID60215315; Mesilate, Phentolamine; Mesylate, Phentolamine; RefChem:55851; Methanesulfonate, Phentolamine; DTXCID60137806; 2-(N-p'-Tolyl-N-(m'-hydroxyphenyl)aminomethyl)imidazoline Monomethanesulfonate

GHS hazard classification

Reported hazard statements	H302 (100%), H312 (95.2%), H315 (97.6%), H319 (97.6%), H332 (95.2%), H335 (92.9%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

H312 (95.2%): Harmful in contact with skin [Warning Acute toxicity, dermal]

What the public record says

Phentolamine Mesylate · CAS 65-28-1 · C18H23N3O4S. UNII Y7543E5K9T.

Physical description and handling notes

Source: PubChem / Wikidata; the batch COA governs where values differ.